Novavax, Inc. this week announced it has completed purification of a virus-like particle (VLP) vaccine candidate for the emerging H7N9 influenza and has initiated animal immunogenicity and efficacy studies.
The company began work on the strain in early April. Analysis and optimization of the gene sequences for the key viral hemagglutinin (HA) and Continue reading
The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense: Continue reading
Medicago Inc., a biopharmaceutical company focused on developing vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), this week announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
“To our knowledge, Medicago Continue reading
The National Institute for Allergy and Infectious Diseases has made three contract awards for the Simian Vaccine Evaluation Unit (SVEU) effort for facilities and resources to conduct non-human primate immunogenicity research and pilot studies for new antivirals and vaccines.
The SVEU contracts will provide non-human primate (NHP) resources that primarily support Continue reading
The Defense Advanced Research Projects Agency has awarded several contracts in support of advancing Methods for Explosive Detection at Standoff (MEDS). The vision of the program is to develop methods that permit rapid detection of bulk explosives embedded within an opaque medium with high water content. Continue reading
Soligenix, Inc., announced this week it will jointly develop a treatment for Melioidosis, an infectious disease caused by a Gram-negative bacterium, Burkholderia pseudomallei, through a worldwide exclusive collaboration with Intrexon.
Burkholderia pseudomallei and the closely related Burkholderia mallei are considered Continue reading
Nominations are still being accepted for the Non-Conventional Threat CBRNe Awards, which recognize the leading CBRNe products, solutions and developments in the international CBRNe Community.
The awards are designed to highlight those companies that have delivered excellence and innovation, allow for the CBRNe Community Continue reading
The U.S. federal government this week announced a notable contract awards related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense: Continue reading